ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh
Open Access
- 1 September 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 14, 2429-2436
Abstract
Purpose: The world is heavily suffering from the COVID-19 pandemic for more than a year, with over 191 million confirmed cases and more than 4.1 million deaths to date. Previous studies have explored several risk factors for coronavirus disease 2019 (COVID-19), but there is still a lack of association with ABO blood type. This study aimed to find out the relationship between the ABO blood group and COVID-19 outcomes in Bangladesh. Subjects and Methods: This retrospective cross-sectional study was conducted in the intensive care unit (ICU) of a tertiary-level COVID-dedicated hospital in Dhaka city, Bangladesh, between April 2020 and November 2020. Records from 771 critically ill patients were extracted who were confirmed for COVID-19 by reverse transcriptase-polymerase chain reaction (RT-PCR) assay, and blood grouping records were available in the health records. Results: The blood groups were 37.35%, 17.38%, 26.46%, and 18.81% for A, B, AB, and O type, respectively. Clinical symptoms were significantly more common in patients with blood type A (p < 0.05). Patients with blood type A had higher WBC counts and peak serum ferritin levels and both were statistically significant (p < 0.001). Patients with blood type A had a greater need for supplemental oxygen, and they were more likely to die in comparison to the patients with other blood types (p < 0.05). In multivariable analysis, our primary outcome death was significantly associated with blood type A (AOR: 3.49, 95% CI: 1.57– 7.73) while adjusting for age, male gender, and non-communicable diseases. Conclusion: Based on this study results, it can be concluded that the COVID-19 patients with blood type A have a higher chance of death and other complications. The authors recommend blood grouping before treating the COVID-19 patients, and healthcare workers should prioritize treating the patients based on that result.Keywords
This publication has 32 references indexed in Scilit:
- Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, ChinaJAMA, 2020
- New Insights Into CRASP-Mediated Complement Evasion in the Lyme Disease Enzootic CycleFrontiers in Cellular and Infection Microbiology, 2020
- U1 snRNP regulates cancer cell migration and invasion in vitroNature Communications, 2020
- Blood group AB is associated with severe forms of dengue virus infectionVirusDisease, 2018
- ABO blood grouping in Egyptian children with rotavirus gastroenteritisGastroenterology Review, 2017
- The ABO Histo-Blood Group and AKI in Critically Ill Patients with Trauma or SepsisClinical Journal of the American Society of Nephrology, 2015
- Blood Groups in Infection and Host SusceptibilityClinical Microbiology Reviews, 2015
- Comparative frequency and allelic distribution of ABO and Rh (D) blood groups of major tribal communities of southern Bangladesh with general population and their determinantsEgyptian Journal of Medical Human Genetics, 2015
- Association of ABO and Rh Blood Groups to Blood-Borne Infections among Blood Donors in Tehran-Iran2014
- ABO Blood Group and Susceptibility to Severe Acute Respiratory SyndromeJAMA, 2005